Apotheken | Arzt | Interaktionen | Medikamente | MiGeL | Services | Spital | Zulassungsi.
C10BX - Hmg Coa Reductase Inhibitors, Other CombinationsATC-DDD Version 2016. Source: WHO
C - Cardiovascular System
C10 - Lipid Modifying Agents

The DDDs are based on the treatment of hypercholesterolemia.

C10B - Lipid Modifying Agents, Combinations

Fixed combinations of blood glucose-lowering drugs and lipid modifying agents are classified in A10B.

For fixed combinations in C10B the DDD is based on dosing frequency only. This implies that 1 UD (1 tablet) is the DDD for all products given once daily and the DDD for products given twice daily and three times daily is 2 UD (2 tablets) and 3 UD (3 tablets) respectively.

C10BX - Hmg Coa Reductase Inhibitors, Other Combinations

Combinations with e.g. ACE inhibitors, angiotensin II antagonists, calcium channel blockers or diuretics are classified in C10BX.

The DDD for the fixed combination of rosuvastatin and valsartan is 1 UD (1 tablet), regardless of strength.

2020 ©ywesee GmbH
Einstellungen | Hilfe | FAQ | Anmeldung | Kontakt | Home